These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9273241)

  • 41. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 42. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of vasoactive substances in the treatment of cardiovascular diseases].
    Heine H; Schmidt H; Faulhaber HD; Anders G
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2090-3. PubMed ID: 4405750
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hypertension therapy with beta blocker plus diuretic. "We are at the point of leaving behind an era"].
    Dahlöf B
    MMW Fortschr Med; 2005 Mar; 147(12):8. PubMed ID: 15832781
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Devereaux PJ; Ghali WA
    N Engl J Med; 1997 May; 336(20):1452-3; author reply 1453-4. PubMed ID: 9148147
    [No Abstract]   [Full Text] [Related]  

  • 46. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Ho T; Taussig D; McAnulty G
    N Engl J Med; 1997 May; 336(20):1452; author reply 1453-4. PubMed ID: 9148145
    [No Abstract]   [Full Text] [Related]  

  • 50. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When heart patients need non-heart operations.
    Johns Hopkins Med Lett Health After 50; 1999 Jun; 11(4):3. PubMed ID: 10377900
    [No Abstract]   [Full Text] [Related]  

  • 52. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 53. Atenolol induced memory impairment: a case report.
    Ramanathan M
    Singapore Med J; 1996 Apr; 37(2):218-9. PubMed ID: 8942269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intrinsic sympathicomimetic activity of beta blockers].
    Beckers J
    Rev Med Liege; 1988 Oct; 43(19):613-22. PubMed ID: 2903532
    [No Abstract]   [Full Text] [Related]  

  • 55. Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
    Cazzola M; Matera MG
    Am J Respir Crit Care Med; 2008 Oct; 178(7):661-2. PubMed ID: 18796649
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Petros JA
    N Engl J Med; 1997 May; 336(20):1452; author reply 1453-4. PubMed ID: 9148146
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in the platelet-vascular system of hemostasis in patients with ischemic heart disease and hypertension after the treatment].
    Zadionchenko VS; Kamenker ES; Chikvashvili IA
    Kardiologiia; 1989 Oct; 29(10):51-4. PubMed ID: 2575682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Blockage of beta-adrenergic receptors in the clinical course of the cardio-vascular system (review of the literature)].
    Gorodinskaia VIa; Simon IB
    Vrach Delo; 1967 Nov; 11():24-31. PubMed ID: 4392169
    [No Abstract]   [Full Text] [Related]  

  • 59. Expanding our therapeutic options: Beta blockers for breast cancer?
    Ganz PA; Cole SW
    J Clin Oncol; 2011 Jul; 29(19):2612-6. PubMed ID: 21632500
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Reis SE; Feldman AH
    N Engl J Med; 1997 May; 336(20):1453; author reply 1453-4. PubMed ID: 9148148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.